Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients - PWR 12.02.2022
powernephron
Published on Dec 13, 2022
Dr. Karen Shalansky, Dr. Kevin Kwok, Dr. Hilary Wu present, "Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients."
Category
- Your Subscription
powernephron -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
16 views 1290 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
15 views 1085 days ago -
24:13
Gestational and Chronic Hypertension - CRASH! Medical Review Series
12 views 834 days ago -
47:17
Renin angiotensin system blockade in COVID-19: A tumultuous year in review
14 views 1266 days ago -
52:24
New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF
16 views 1266 days ago -
30:35
Christopher Blosser, MD - Cancer in Patients with Kidney Disease
15 views 1088 days ago